Cargando…

The Italian multiple sclerosis register

The past decade has seen extraordinary increase in worldwide availability of and access to several large multiple sclerosis (MS) databases and registries. MS registries represent powerful tools to provide meaningful information on the burden, natural history, and long-term safety and effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trojano, Maria, Bergamaschi, Roberto, Amato, Maria Pia, Comi, Giancarlo, Ghezzi, Angelo, Lepore, Vito, Marrosu, Maria Giovanna, Mosconi, Paola, Patti, Francesco, Ponzio, Michela, Zaratin, Paola, Battaglia, Mario Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329744/ https://www.ncbi.nlm.nih.gov/pubmed/30426289 http://dx.doi.org/10.1007/s10072-018-3610-0

Ejemplares similares

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
por: Mosconi, Paola, et al.
Publicado: (2023)

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study
por: Pastò, Luisa, et al.
Publicado: (2012)

Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis
por: Ponzio, Michela, et al.
Publicado: (2015)

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
por: Iaffaldano, Pietro, et al.
Publicado: (2022)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
por: Sormani, Maria P., et al.
Publicado: (2021)

Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis
por: Solari, Alessandra, et al.
Publicado: (2017)

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
por: Pecori, Chiara, et al.
Publicado: (2014)

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study
por: Giannini, Marta, et al.
Publicado: (2012)

Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
por: Comi, Giancarlo, et al.
Publicado: (2013)

Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes
por: Manacorda, Tommaso, et al.
Publicado: (2020)

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
por: D’Amico, Emanuele, et al.
Publicado: (2021)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register
por: Bergamaschi, Roberto, et al.
Publicado: (2022)

Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)
por: Pilotto, Silvy, et al.
Publicado: (2021)

Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial
por: Solari, Alessandra, et al.
Publicado: (2015)

An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases
por: Salvetti, Marco, et al.
Publicado: (2019)

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)
por: Patti, Francesco, et al.
Publicado: (2020)

Natalizumab in the pediatric MS population: results of the Italian registry
por: Ghezzi, Angelo, et al.
Publicado: (2015)

The economic impact of comorbidity in multiple sclerosis
por: Ponzio, Michela, et al.
Publicado: (2022)

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
por: Comi, Giancarlo, et al.
Publicado: (2020)

The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population
por: Goretti, Benedetta, et al.
Publicado: (2014)

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study
por: Bastianello, Stefano, et al.
Publicado: (2011)

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
por: Sormani, Maria Pia, et al.
Publicado: (2021)

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study
por: Patti, Francesco, et al.
Publicado: (2013)

Open-access clinical trial registries: the Italian scenario
por: Mosconi, Paola, et al.
Publicado: (2012)

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
por: Zaratin, Paola, et al.
Publicado: (2022)

Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes
por: Brichetto, Giampaolo, et al.
Publicado: (2020)

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
por: Ponzano, Marta, et al.
Publicado: (2022)

Psychosocial Care for Adult Cancer Patients: Guidelines of the Italian Medical Oncology Association
por: Caminiti, Caterina, et al.
Publicado: (2021)

MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients
por: Serana, Federico, et al.
Publicado: (2014)

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
por: Patti, F, et al.
Publicado: (2016)

Barriers to exercise and the role of general practitioner: A cross-sectional survey among people with multiple sclerosis
por: Correale, Luca, et al.
Publicado: (2022)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis
por: Pau, Massimiliano, et al.
Publicado: (2015)

Erratum to: ‘Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial’
por: Solari, A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gvejfq2gv8d0e338h54oaj6mv9